Rhumbline Advisers increased its position in Xylem Inc. (NYSE:XYL - Free Report) by 6.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 450,736 shares of the industrial products company's stock after acquiring an additional 27,046 shares during the period. Rhumbline Advisers owned about 0.19% of Xylem worth $53,845,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Xylem by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after purchasing an additional 303,854 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Xylem by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock worth $671,623,000 after acquiring an additional 135,492 shares during the period. Impax Asset Management Group plc raised its holdings in shares of Xylem by 231.5% during the fourth quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock valued at $644,039,000 after purchasing an additional 3,883,845 shares during the last quarter. Royal Bank of Canada boosted its holdings in Xylem by 7.9% in the fourth quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after purchasing an additional 320,500 shares during the last quarter. Finally, Invesco Ltd. grew its position in Xylem by 9.8% in the 4th quarter. Invesco Ltd. now owns 4,009,907 shares of the industrial products company's stock worth $465,229,000 after purchasing an additional 359,276 shares during the period. 87.96% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research firms have recently weighed in on XYL. Raymond James raised Xylem to a "hold" rating in a report on Thursday, May 15th. Royal Bank of Canada raised their target price on Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Citigroup reduced their price target on shares of Xylem from $152.00 to $134.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Stifel Nicolaus raised their price objective on shares of Xylem from $140.00 to $141.00 and gave the stock a "buy" rating in a report on Wednesday, April 30th. Finally, Robert W. Baird reduced their target price on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $143.71.
Check Out Our Latest Analysis on Xylem
Xylem Price Performance
NYSE:XYL traded down $0.28 during trading hours on Wednesday, hitting $126.87. 1,045,718 shares of the stock traded hands, compared to its average volume of 1,396,870. The company has a market cap of $30.87 billion, a price-to-earnings ratio of 34.66, a price-to-earnings-growth ratio of 2.33 and a beta of 1.10. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $143.50. The stock has a 50 day moving average price of $118.19 and a 200 day moving average price of $121.61. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 0.19.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Tuesday, April 29th. The industrial products company reported $1.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The company had revenue of $2.07 billion for the quarter, compared to analysts' expectations of $2.04 billion. During the same quarter in the previous year, the company earned $0.90 EPS. Xylem's revenue for the quarter was up 1.8% on a year-over-year basis. Sell-side analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Thursday, May 29th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date of this dividend is Thursday, May 29th. Xylem's dividend payout ratio (DPR) is 43.01%.
Xylem Company Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.